31/10/2010Intronix Technologies Corporation
Toronto, Ontario, October 31, 2010 – Intronix Technologies Corporation will show their “new and improved” needle EMG (electromyography) guided injection system, Myoguide, at MEDICA 2010, November 17-20, in Düsseldorf, Germany.
The updated Myoguide release complements the launch of Myoguide DOC. Myoguide DOC, is our new “tablet friendly” injection documentation software package. Myoguide DOC is designed for documentation of patient encounters related to injection of pain management and neuromodulator drugs.
“Myoguide presents a comprehensive integrated system that was developed to better satisfy the needs of leading Neurologists, Physiatrists and clinicians injecting neuromodulators such as: Botox©, Myobloc©, Dysport©, and Xeomin©, for the management of pain, movement disorders, spastic muscle management and cosmetic applications” explains Dr. Evan Friedman, Intronix President and founder of the 26-year-old company. “
Myoguide updates include a sharper, higher contrast, LCD display. Refined features such as “stimulation pause”, and “audio mute” are hallmarks of the the unique design.
The unsurpassed performance of Myoguide needle EMG guided injection device, paired up with Myoguide DOC, strengthen the value of the Myoguide system. In short, The Myoguide System helps make treatment more beneficial.
To see how it works, or simply for more information on Myoguide, and the new Myoguide DOC, please visit us at MEDICA 2010 Düsseldorf, Germany: Hall #16, Booth # G42 (Ontario-Canada Pavilion), November 17-20, 2010.